Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Q2 2016 · 10-Q
Revenue$4.54B$4.54B+6.2% vs Q2 2015 Net income—
EPS Diluted$1.30$1.30+2.4% vs Q2 2015 Gross Profit$2,078,000,000+7.0% Operating Income$637,600,000+7.0% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
Operating Cash Flowderived$913,600,000+19.4% Free Cash Flowderived$798,800,000+19.3% Margins · derivedGross margin45.8%+0.4 pt vs Q2 2015
Operating margin14.1%+0.1 pt vs Q2 2015
ended Jul 2, 2016 · filed Aug 5, 2016 · 34 d after period end